Company Overview

IDH is a leading consumer healthcare company in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria and is proudly woman-led. A long track record for quality and safety has earned the Group a trusted reputation, as well as internationally-recognised accreditations for its portfolio of over 3,000 diagnostics tests. From its base of over 601 branches, the Company will continue to add laboratories through a Hub, Spoke and Spike business model that provides a scalable platform for efficient expansion.

The Company aims to be a leading healthcare provider in every community and region that it serves, becoming every doctor and patient’s first choice for quality, accurate diagnostic testing and cost effective services.

One of IDH’s philosophies is its strict adherence to providing accurate and timely diagnostic services, which is why we accredit our laboratories through stringent international bodies such as College of American Pathologists (CAP), the International Organization for Standardization (ISO), the Joint Commission International (JCI), the Jordanian Accreditation System (JAS), and the Healthcare Accreditation Council (HCAC). Most recently, the Group successfully obtained ACR (American College of Radiology) accreditation for both the venture’s nuclear medicine (NucMed) and ultrasound units, making Al-Borg Scan the first radiology centre in Africa, and one of the only radiology facilities in the Middle East, to boast this prestigious certification. IDH has also earned the Egyptian government’s full General Authority for Healthcare Accreditation and Regulation (GAHAR) for 10 of its labs, making it the private provider with the most accredited labs and enabling to play a frontline role in supporting the government’s roll-out of universal insurance. Recently, IDH unveiled its new core values represented by the acronym C.A.R.E: Customer@Heart, Raising the Bar, All in One, and Excellence. These values emphasize continuous improvement, excellence, and always adhering to the highest standards through the collective efforts of our dedicated team. Above all, they place our customers at the forefront of our operations, consistently delivering patient-focused care and enhancing our relationships with them. IDH is also committed to ethical values that underscore integrity and fairness as we strive for superior operational and financial performance.

Vision & Mission Statement

Our Vision & Purpose

Our purpose is to elevate our communities’ health welfare through the provision of world-class medical services.

Our Mission

We aim to provide exceptional care to our communities and build brand recognition by offering a diverse range of world-class medical services while leveraging the expertise of our team and partners to drive innovation.

IDH New Core (C.A.R.E) Values

Customer@Heart

Placing our customers at the forefront, delivering patient-focused care and enhancing relationships.

Raise the Bar

Continuously striving for improvement, pushing boundaries to achieve excellence.

All in One

Embracing collaboration and teamwork, leading to greater success and innovation.

Excellence

Committing to the highest standards of performance and professionalism.

Key Facts

EGP 4.1 BN

FY23 REVENUES

601

BRANCH LABS AS AT 31 December 2023

+3,000

DIAGNOSTICS TESTS

8.5 MN

PATIENTS SERVED IN 2023

OUR SERVICES

Pathology

Immunology
Microbiology
Haematology
Endocrinology
Clinical Chemistry
Molecular Biology
Parasitology
Histopathology
Genetics

Radiology

PET-CT
MRI
CT
Mammography
Ultrasound
X-Ray
Electromyography
Electroencephalography
Electrocardiogram

Our Geography

Our Brands

Our Patients

Our Accreditations